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The glycosome, a peroxisome-related organelle, is essential for the growth and survival of trypanoso-
matid protozoa. In glycosome biogenesis, Pex5p recognizes newly synthesized glycosomal matrix pro-
teins via peroxisome-targeting signal type-1 (PTS-1) and transports them into glycosomes through an
interaction with Pex14p, a component of the matrix protein import machinery on the glycosomal
membrane. Knockdown of the PEX5 or PEX14 with RNAi has been shown to inhibit the growth of Try-
panosoma brucei. Thus, compounds that inhibit the interaction of TbPex5p–TbPex14p are expected to
become lead compounds in the development of anti-trypanosomal drugs. Here, we report a homogenous
time-resolved ﬂuorescence (HTRF) assay for the screening of compounds that inhibit the TbPex5p–
TbPex14p interaction. The binding of GST-TbPex14p and TbPex5p-His with or without additional com-
pounds was evaluated by measuring the energy transfer of the HTRF pair, using a terbium-labeled anti
GST antibody as the donor and an FITC-labeled anti His antibody as the acceptor. The assay was per-
formed in a 384-well plate platform and exhibits a Z’-factor of 0.85–0.91, while the coefﬁciency of var-
iation is 1.1–7.7%, suggesting it can be readily adapted to a high-throughput format for the automated
screening of chemical libraries. We screened 20,800 compounds and found 11 compounds that inhibited
energy transfer. Among them, in a pull-down assay one compound exhibited selective inhibition of
TbPex5p–TbPex14p without any HsPex5p–HsPex14p interaction.
& 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Trypanosoma brucei is responsible for the fatal human disease
of sleeping sickness in tropical and subtropical parts of the world.
Many attempts to develop therapeutic agents have been carried
out and currently there are a few drugs available for treatment.
However, these drugs possess severe side effect and emerging
resistant parasite has been reported [1]. Therefore, the develop-
ment of new, effective and safe anti-trypanosomal drugs isB.V. This is an open access article u
ﬂuorescence; PTS-1, peroxi-
sferase; HTS, high-through-
ransfer
manaka).urgently needed.
The trypanosomatid possesses certain unique organelles called
glycosomes. These are peroxisome-related organelles that contain
the majority of the enzymes involved in the glycolytic pathway [2].
It has been shown that T. brucei grows in a manner entirely de-
pendent on aerobic glycolysis in order to generate ATP in the
bloodstream form, since glycolysis is the sole source of energy [3].
In contrast, in the insect midgut, glucose is only available brieﬂy
after the ﬂy has taken a blood meal, so the procyclic form of the
trypanosome has to expand the metabolic pathway in order to
metabolize amino acids such as proline and threonine in mi-
tochondria [4]. Although ATP is synthesized in mitochondria in the
procyclic form of the trypanosome, impairment of glycosome
biogenesis is lethal in a medium containing glucose [5]. Thus, the
proteins involved in the biogenesis of the glycosome arender the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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The glycolytic enzymes possess either peroxisome-targeting
signal type-1 (PTS-1) at the COOH-terminus or PTS-2 at the
NH2-terminus. Each of the receptor proteins TbPex5p and TbPex7p
in the cytosol recognizes the newly synthesized enzymes, and
subsequently each complex, TbPex5p with the PTS-1 protein or
TbPex7p with the PTS-2 protein, is translocated into the glycosome
through an interaction with TbPex14p, a component of the matrix
protein import machinery on the glycosomal membrane. Recently,
depletion of Pex5p, Pex7p or Pex14p with RNAi has been shown to
cause mislocalization of the enzymes to the cytosol and to exert a
profound effect on the growth of T. brucei, in most cases followed
by the death of the parasite [6,7].
Pex5p is composed of two distinct parts: an NH2-terminal half
of low similarity except for multiple pentapeptide WXXXF/Y re-
peats and a highly conserved COOH-terminal half comprising se-
ven tetratricopeptide repeat (TPR) motifs [8]. The WXXXF/Y motif
has been shown to be essential for the interaction with Pex14p [9],
while the TPR region was shown to mediate the binding to PTS-1
containing proteins [10]. Pex14p, a membrane-anchored protein, is
a central component in the glycosomal protein import machinery
[7]. The NH2-terminal region is composed of 21–70 amino acids
that are highly conserved among species and bind with Pex5p,
Pex13p and Pex19p [11,12]. Recently, the binding mode of the
WXXXF/Y motif with the NH2-teminal conserved domain of
Pex14p was reported in mammal and T. brucei [13]. The binding
mode between Pex5p and Pex14p is comparable in the trypano-
some and humans. However, the overall amino acid sequence
identity of TbPex5p and TbPex14p with their human counterparts
(HsPex5p and HsPex14p) is only 20% and 27%, respectively. The
amino acid sequence of Pex5p around the Pex14p binding site is
also different between the trypanosome and humans (See Results
and discussion). This difference may afford a target for anti-try-
panosomal drugs.
A homogenous time-resolved ﬂuorescence (HTRF)-based assay
has been developed for the purpose of high-throughput screening
(HTS) for drug targets [14]. This method combines ﬂuorescence
resonance energy transfer (FRET) with time-resolved measure-
ment that allows the elimination of short-lived background phe-
nomena. In the case of an analysis of protein-protein interaction, a
pair of antibodies against target proteins that are labeled with the
respective HTRF donor and acceptor ﬂuorophores is used. In this
study, we developed an HTRF-based HTS assay speciﬁcally de-
signed for screening chemical compounds that inhibit the
TbPex5p–TbPex14p interaction. The screening of a chemical library
was performed in a 384-well plate platform. We found one com-
pound that inhibited the interaction of TbPex5p–TbPex14p, but not
HsPex5p–HsPex14p.2. Materials and methods
2.1. Materials
The Lumi4s-Tb cryptate conjugated anti Glutathione S-trans-
ferase (terbium-anti GST) antibody and FITC conjugated anti His
(FITC-anti His) antibody were purchased from Cisbio Bioassay
(Codolet, France) and Abcam (Cambridge, MA), respectively. The
rabbit anti GST antibody was prepared by immunization of rabbits
with puriﬁed recombinant GST. Rabbit anti HsPex5p was kindly
provided by Dr. Nobuyuki Shimozawa (Gifu University).
2.2. Plasmid construction
All of the primers used in this study are listed in Supplemen-
tary Table 1. The details on the construction of the expressionvectors for GST tagged T. brucei and human Pex14p and His-tagged
T. brucei and human Pex5p are provided in the Supplemental
Methods. To prepare the expression plasmids for the mutated
TbPex5p(Δ1,3)-His, a KOD -Plus- Mutagenesis Kit (TOYOBO, Osaka,
Japan) was used according to the manufacturer's instructions.
2.3. Puriﬁcation of recombinant proteins
All of the recombinant proteins in this study were expressed in
E. coli BL21(DE3)pLysS and puriﬁed using tag-afﬁnity resins. The
details of the puriﬁcation procedures are provided in the Supple-
mental Methods section.
2.4. HTRF-based HTS
Two hundred nl of the compounds in DMSO (2 mM each) were
applied to 384-well plates (Greiner-Bio-One, Austria) using POD™
Automation (Labcyte Inc., Sunnyvale, CA). The ﬁnal concentration
of each compound was ﬁxed at 20 mM. The same amount of DMSO
was applied to the negative and positive control wells in lane
2 and lane 23, respectively. Then, TbPex5p-His and GST-TbPex14p
(16 nM each) in 10 ml of HTS buffer (50 mM Hepes-NaOH, pH7.5,
150 mM NaCl, 1 mM EDTA, 1 mM DTT, 0.02% Triton X-100, 10%
glycerol, and 0.1% BSA) were applied to the wells in lane 23 (po-
sitive control) and lanes 3–22 (compounds), and 10 ml of HTS
buffer were applied to the wells in lane 2 as a negative control
using Multidrop Combi reagent dispenser (Thermo Fisher Scien-
tiﬁc, Waltham, MA). After the plates were incubated at room
temperature for 1 h, 10 ml of HTS buffer containing the terbium-
anti GST antibody and FITC-anti His antibody were added. The
plates were then incubated at room temperature for 2 h before
ﬂuorescent signal detection. The ﬂuorescence intensities were
measured at both 520 nm and 490 nm using an excitation wave-
length of 337 nm with PHERAstar Plus (BMG LABTECH, Offenburg,
Germany).
The HTRF ratio was calculated using the following equation:
(Intensity of 520 nm)/(Intensity of 490 nm)100. The accuracy of
the assay was evaluated by the Z’-factor and was calculated with
the following equation: 1–3 (SDmaxþ SDmin)/(Avmax – Avmin),
where SD is the standard deviation of the positive control (the
maximum HTRF ratio; with TbPex5p-His and GST-TbPex14p,
without compound) or the negative control (the minimum HTRF
ratio; without TbPex5p-His, GST-TbPex14p, and compound) and Av
is the mean of the positive or negative control. The inhibition ratio
(Inhibition %) was calculated using the following equation: 100
{1 – (Rcompound–Avmin)/(Avmax–Avmin)}, where Rcompound is the
HTRF ratio of the compound in the assay well.
2.5. Pull-down assay
GST pull-down assay was performed as described below.
TbPex5p-His and GST-TbPex14p (64 nM each) were incubated at
room temperature for 2 h in 200 ml of pull-down buffer (50 mM
Hepes-NaOH, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 mM DTT, 0.02%
Triton X-100, 10% glycerol and 0.01% BSA) with 3.2 ml or 16 ml of
compound in DMSO (10 mM or 2 mM, respectively). The ﬁnal
concentration of each compound was ﬁxed at 160 mM in order to
examine the effect at the same ratio of the compound to TbPex5p-
His and GST-TbPex14p upon HTS (the concentration of the com-
pound against TbPex5p-His and GST-TbPex14p was 2500 fold).
After this incubation, the mixture was further incubated with 20 ml
of glutathione-Sepharose 4B resin equilibrated with pull-down
buffer at room temperature for 1 h. The resins were washed four
times with 250 ml of pull-down buffer. The bound proteins were
eluted in SDS-sample buffer and analyzed by SDS-PAGE followed
by immunoblot analysis with an anti GST antibody or anti His
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His-tagged pull-down assay was performed using the same
method as the GST pull-down assay for evaluation of His-HsPex5p
interaction with GST-HsPex14p. In the His tagged pull-down assay,
cOmpelte His-tag puriﬁcation resin (Roche Diagnostics GmbH,
Mannheim, Germany) was used instead of glutathione-Sepharose
4B resin. The bound proteins were eluted in SDS-sample buffer
and analyzed by SDS-PAGE followed by immunoblot analysis with
an anti GST antibody or anti HsPex5p antibody.
The amount of each of the proteins binding to the resin was
quantiﬁed by using the image analysis software Image J [15]. The
inhibition % was calculated by using the following equation:
100 {1–(Compoundprey/Compoundbait)/(Controlprey/Controlbait)},
where the “Compound” is the band intensity of the prey protein
(TbPex5p-His or GST-HsPex14p) or the bait protein (GST-TbPex14p
or His-HsPex5p) in the corresponding compound lane. The “Con-
trol” is the band intensity of the prey protein or the bait protein in
the positive control (8% DMSO without compound) lane.
To calculate IC50 of compound i, at a ﬁnal concentration of 0.1,
0.3, 1, 3, 10, 30, 100, 300 or 500 μM compound i was incubated
with TbPex5p and TbPex14p and GST pull-down assay was per-
formed as described above. Inhibition ratios by various con-
centration of compound i were calculated by setting 100% in-
hibition at 500 μM compound i and 0% inhibition at control
without inhibitor. IC50 was obtained by 4-parameter logistic curve.Fig. 2. Evaluation of the interaction of TbPex14p with TbPex5p. (A) The increase in
the ﬂuorescent ratio by the interaction of GST-TbPex14p with TbPex5p-His. WT,
wild type TbPex5p-His; Δ1.3, mutant TbPex5p-His with the deleted ﬁrst and third
WXXXF/Y motifs. GST-TbPex14p (25 nM) and TbPex5p-His or TbPex5p(Δ1,3)-His
(25 nM) were incubated with labeled antibodies against GST and His (250 or 500
dilution; closed or open bar, respectively). (B) Optimization of the GST-TbPex14p
and TbPex5p-His concentration for detecting the signal ratio by the interaction. The
ﬁnal concentrations used were 0–250 nM, with a three-fold serial dilution for GST-
TbPex14p and TbPex5p-His or TbPex5p(Δ1,3)-His. The closed diamond shows the
assay result for TbPex5p-His and GST-TbPex14p, and the open square shows the
assay result for TbPex5p(Δ1,3)-His and GST-TbPex14p.3. Results and discussion
3.1. Optimization and validation of the HTRF assay
The interaction of GST-TbPex14p with TbPex5p-His was eval-
uated by energy transfer of the HTRF pair, using a terbium-anti
GST antibody as the donor and an FITC-anti His antibody as the
acceptor. When the donor ﬂuorophore was excited at 337 nm, a
portion of the emitted energy directly transferred to the acceptor
ﬂuorophore in the case where two ﬂuorophores exist in close
proximity. This results in a decreased emission of the donor at
490 nm as well as an increase in the acceptor emission at 520 nm
(Fig. 1). We thus evaluated the binding of GST-TbPex14p with
TbPex5p-His by the ratio of the ﬂuorescence at 520 nm/
490 nm100. First, a speciﬁc increase of the ratio by the inter-
action of GST-TbPex14p (25 nM) with TbPex5p-His (25 nM) was
conﬁrmed by using TbPex5p(Δ1,3)-His as the negative control. As
TbPex5p(Δ1,3)-His lacks the ﬁrst and third WXXXF/Y motif, it is
unable to bind TbPex14p [16]. An increase in the HTRF ratio was
observed in the case of wild type TbPex5p. In contrast, the ratio
did not increase in the case of mutant TbPex5p(Δ1,3)-His (Fig. 2
(A)). We then ﬁxed the concentration of terbium-anti GST520 nmFRET
337 nm 490 nm
His
Pe
x1
4p
GST
add com
Tb FITC
Fig. 1. Principles of the method for detecting the interaction between GST-TbPex14p an
labeled as the donor and acceptor, respectively. The HTRF signals are generated when eac
with TbPex5p-His. Tb means terbium in this ﬁgure.antibody and FITC-anti His antibody at 500-fold dilution and op-
timized the concentration of GST-TbPex14p with TbPex5p-His. As
shown in Fig. 2(B), the maximum value was observed with the
combination of 30 nM of GST-TbPex14p and TbPex5p-His. The
combination of TbPex5p(Δ1,3)-His and GST-TbPex14p did not
display any increase in the ratio.No interacon
FRET OFF
337 nm
520 nm
490 nm
pound
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d TbPex5p-His by HTRF assay. Antibodies against the fused tags GST and His were
h of labeled antibodies exists in close proximity by the interaction of GST-TbPex14p
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the inﬂuence of the DMSO concentration on the ratio was tested.
Less than 1% (v/v) DMSO exerted little inﬂuence on the ﬂuores-
cence ratio. In addition, the HTRF signal that was measured after
the mixing of the antibodies was stable over 5 h (data not shown).
The Z’-factor for the binding of GST-TbPex14p with TbPex5p-His
was calculated to be 0.85–0.91 under different concentrations of
DMSO. The degree of variability was 1.1–7.7% in the positive con-
trol group and the difference in the ﬂuorescence ratio between the
positive group and the control, which lacked GST-TbPex14p and
TbPex5p-His (S/B ratio), was 10. These data suggest that the
HTRF-based assay is reliable in HTS and the speciﬁc signal induced
by the interaction with Pex5p–Pex14p was detectable after 5 h of
incubation.
3.2. Screening of compounds that inhibit the interaction of GST-
TbPex14p with TbPex5p-His
We screened 11,200 compounds of a Protein-Protein Inhibition
library and 9600 compounds of a structurally diverse library
provided by the Drug Discovery Initiative (The University of To-
kyo). In the assay, the concentration of TbPex5p-His and GST-
TbPex14p was ﬁxed at 32 nM (ﬁnal 8 nM per well), and 10 ml of
500-fold diluted mixtures of antibodies were added in each well.
We selected compounds that decreased the value of the ratio to
80% as compared with the positive control.
As shown in Fig. 3(A), 320 compounds (at a ﬁnal concentration
of 20 mM) were assayed in one plate to evaluate inhibition of the
binding between TbPex5p-His and GST-TbPex14p. Each of 16 wells
in lane 2 and lane 23 were used for the negative and positive
controls. Among 20,800 compounds, 139 compounds were se-
lected as hits. We examined the reproducibility of the inhibition
among the 139 compounds using 4 different preparations and
found that 11 compounds exhibited greater than 20% of the in-
hibition ratio with a high level of reproducibility (Fig. 3(B)). The
structure of the compounds is shown in Fig. 4(C) and Supple-
mentary Fig. 1. Purity of the compounds was determined by LC/MS
or HPLC/MS. The purity of compounds except for compound d and
i is almost 100% and the purity of compound i is 91%. TheFig. 3. Screening of chemical compounds by HTRF-based HTS. (A) An example of
the screening on one plate. The abscissa is the number of the compounds used for
screening and the ordinate is the ﬂuorescence ratio. The triangle, square and dia-
mond indicate the positive control, negative control and compound, respectively.
(B) Inhibition % of 11 compounds (20 mM). The data are the mean 7 S. D. of three
experiments.compound d contains mixture of two isomers (51:49) with same
molecular weight.
3.3. Pull-down assay for second screening
In terms of inhibition in this assay system, we cannot exclude
the possibility that the compounds inhibit the interaction of the
antibodies with GST or His-tag. Therefore, we performed a pull-
down assay using TbPex5p-His and GST-TbPex14p. In this experi-
ment, we used human His-Pex5p and GST-Pex14p to analyze the
speciﬁcity.
To evaluate the inhibitory effect of the 11 compounds against
the interaction of TbPex5p-His and GST-TbPex14p, we examined
their effect by pull-down assay. As a positive control the TbPex5p-
His was co-precipitated with GST-TbPex14p in the presence of a
ﬁnal concentration of 1.6% or 8% DMSO, since the compounds were
dissolved at the concentration of 2 mM or 10 mM in DMSO, and
the ﬁnal concentration of the compounds was ﬁxed at 160 mM in
order to keep the molar ratio of the compounds to TbPex5p and
TbPex14p the same as in the HTRF assay. Almost the same amount
of TbPex5p-His was co-precipitated with GST-TbPex14p in the
presence of 8% or 1.6% DMSO (Fig. 4 upper panel, lanes 4 and 5).
However, no TbPex5p-His was co-precipitated in the absence of
GST-TbPex14p (lane 3). Under these conditions, the amount of
TbPex5p-His that co-precipitated was strongly reduced by com-
pound i (lane 14). In addition, the amount of TbPex5p-His that co-
precipitated was reduced by compounds j and k. However, GST-
TbPex14p was also reduced, suggesting the compounds inhibit the
binding of GST-TbPex14p to the resin along with the binding of
TbPex5p-His to TbPex14p. Furthermore, we investigated the effect
of the compounds on the binding between HsPex5p and HsPex14p.
In the case of GST-HsPex14p, a certain amount of His-HsPex5p and
HsPex5p-His was associated with glutathione-resin. Therefore, we
performed His-tag pull-down assay. As shown in the Fig. 4
(A) lower panel, compound i exerted no effect on the binding,
suggesting that compound i selectively inhibits the interaction of
TbPex5p-His with TbPex14p. The reproducibility of the effect of
compound i–k was conﬁrmed by using 3 different preparations
(Fig. 4(B)). As a result, compound i inhibited the interaction of
TbPex5p with TbPex14p approximately 80%. IC50 of compound i
was determined 150788.2 μM by the pull down assay of 3 dif-
ferent experiments.
The compound i is 4-{[2-(methoxycarbonyl)-5-(2-thienyl)-3-
thienyl]amino}-4-oxo-2-butenoic acid (Fig. 4(C)). The mechanism
by which the compound inhibits the interaction between TbPex5p
and TbPex14p is unknown at present. It is unlikely the compound
directly inhibits the interaction of the WXXXF/Y motif with the
NH2-terminal binding site of TbPex14p since the structure of the
NH2-terminus of Pex14p is highly conserved between T. brucei and
humans [16–19]. The compound i possesses two carbonic acids
and an amide bond. In addition, the compound i possesses het-
eroatoms and becomes a donor or acceptor of a protein hydrogen
bond. The properties of the compound suggest it may interact with
several proteins that have a cavity-like structure. There is no si-
milarity of the structure among compounds i, j and k. However,
the nitro group and α-amino ether in compound j and the phe-
nolic hydroxyl group in compound k make generally hydrogen
bond. The compounds might be possible to become incorporated
in the pocket of proteins.
The binding mode between Pex5p and Pex14p is very similar
between trypanosome and human [16], but the overall homology
between the human and trypanosome Pex5p is 20% and Pex14p is
27%. In addition, the amino acid sequences of Pex5p around the
Pex14p binding motif, WXXXF/Y, are different between the try-
panosome and humans (Supplementary Fig. 2). The amino acid
sequences of Pex14p around Pex5p binding site are also different
Fig. 4. Effect of 11 compounds on the interaction of both T. brucei and human Pex5p and Pex14p. (A) Effect of 11 compounds on the interaction of TbPex5p with TbPex14p
(upper panel), and HsPex5p with HsPex14p (lower panel). The TbPex5p–TbPex14p interactions were assessed by GST pull-down assay and the HsPex5p–HsPex14p inter-
actions were assessed by His tag pull-down assay. In the GST pull-down assay, the bait protein was GST-TbPex14p and the prey protein TbPex5p-His. In the His tag pull-down
assay, the bait protein was His-HsPex5p and the prey protein GST-HsPex14p. Lane 1 and 2: 25% input of the bait and prey proteins, respectively; lane 3: negative control (N;
without bait protein); lane 4 and 5: positive control (P1; 8% and P2; 1.6% DMSO, respectively); lane 615: compounds with 1.6% DMSO; lane 16: a compound with 8% DMSO.
(B) The reproducibility of 4 compounds. The data are the mean 7 S. D. of three experiments. The pull-down assay was performed as indicated in Fig. 3(A). The inhibition
ratio was judged from the quantiﬁcation of each band by the image analysis software Image J. (C) The chemical structure of the compound i was 4-{[2-(methoxycarbonyl)
5-(2-thienyl)3-thienyl]amino}4-oxo-2-butenoic acid.
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has a speciﬁc interaction with T. brucei Pex5p and/or Pex14p.
Unexpectedly, the compound was found to be an inhibitor of
adipocyte fatty acid binding protein (AFABP/aP2). The compound is
suggested to bind in a structurally similar manner to the long chain
fatty acid in AFABP/aP2 based on the X-ray crystal structure of
AFABP/aP2 with the compound [20]. On the other hand, the three-
dimensional structure of trypanosome and human Pex5p and
Pex14p has not yet been determined. We cannot reveal the binding
site(s) of compound i to TbPex14p and/or TbPex5p at present.
However, TbPex14p and/or TbPex5p may have different binding site
(s) for compound i since TbPex14p and TbPex5p do not seem to
possess a ligand-binding cavity like fatty acid binding proteins. The
compound i is expected to become a seed compound for the de-
velopment of anti-trypanosomal drugs. Whether the compound in-
hibits the growth of T. brucei and whether this inhibition is followed
by the death of the parasite will be taken up in future research.
In addition, this HTRF-based HTS system is highly sensitive and
has the capacity to evaluate rapidly protein-protein interactions.
As a result, the system may prove to be useful in the developmentof a screening system based on the protein-protein interactions
involved in the biogenesis of glycosomes, such as those of Pex7p–
Pex14p, PTS-1 protein–Pex5p and PTS-2 protein–Pex7p.4. Conclusions
The interaction of TbPex5p with TbPex14p is important for
survival of T. brucei. In this study we developed the assay system
designed for screening chemical compounds that inhibit the
TbPex5p–TbPex14p interaction. By using this assay system, we
found one compound that speciﬁcally inhibits TbPex5p–TbPex14p
interaction from 20,800 compounds.Acknowledgements
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